841. Frequency of carbapenemase-encoding genes among Imipenem-Resistant Gram-negative Bacilli isolated from Latin America: Is there a Role for Imipenem/Relebactam? Results from SMART 2017-2018

BACKGROUND: New beta-lactamase inhibitors in combination with beta-lactams such as imipenem /relebactam (IMI/REL) were recently developed and approved for clinical use to overcome the emergence and spread of carbapenemase-producing Gram-negative bacilli (GNB). We evaluated the frequency of carbapene...

Descripción completa

Detalles Bibliográficos
Autores principales: Gales, Ana Cristina, Beirao, Elisa, Tuon, Felipe, Polis, Thales, Rodrigues, Suellen, Negra, Marina Della, Andrade, Tarik, Serra, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776196/
http://dx.doi.org/10.1093/ofid/ofaa439.1030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776196/
http://dx.doi.org/10.1093/ofid/ofaa439.1030

Ejemplares similares